Matisse Pharmaceuticals
Phase 1Saving millions of lives by effectively neutralizing xcytotoxic histones.
Founded
2016
Focus
Small Molecules
About
Saving millions of lives by effectively neutralizing xcytotoxic histones.
Funding History
2Total raised: $23M
Series A$20MAndera PartnersSep 15, 2021
Seed$3MForbionMar 15, 2019
Company Info
TypePrivate
Founded2016
LocationLeiden, Netherlands
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile